244 related articles for article (PubMed ID: 16000960)
1. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples.
Powell DJ; Parker LL; Rosenberg SA
J Immunother; 2005; 28(4):403-11. PubMed ID: 16000960
[TBL] [Abstract][Full Text] [Related]
2. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
[TBL] [Abstract][Full Text] [Related]
3. Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI).
Smetak M; Kimmel B; Birkmann J; Schaefer-Eckart K; Einsele H; Wilhelm M; Kunzmann V
Bone Marrow Transplant; 2008 Apr; 41(7):643-50. PubMed ID: 18037935
[TBL] [Abstract][Full Text] [Related]
4. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.
Cavani A; Nasorri F; Ottaviani C; Sebastiani S; De Pità O; Girolomoni G
J Immunol; 2003 Dec; 171(11):5760-8. PubMed ID: 14634084
[TBL] [Abstract][Full Text] [Related]
5. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
6. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
Stephens LA; Mottet C; Mason D; Powrie F
Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
8. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes.
Venet F; Pachot A; Debard AL; Bohé J; Bienvenu J; Lepape A; Monneret G
Crit Care Med; 2004 Nov; 32(11):2329-31. PubMed ID: 15640650
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
10. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.
Hoffmann P; Eder R; Kunz-Schughart LA; Andreesen R; Edinger M
Blood; 2004 Aug; 104(3):895-903. PubMed ID: 15090447
[TBL] [Abstract][Full Text] [Related]
11. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
Godfrey WR; Spoden DJ; Ge YG; Baker SR; Liu B; Levine BL; June CH; Blazar BR; Porter SB
Blood; 2005 Jan; 105(2):750-8. PubMed ID: 15374887
[TBL] [Abstract][Full Text] [Related]
12. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
13. Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy.
Powell DJ; de Vries CR; Allen T; Ahmadzadeh M; Rosenberg SA
J Immunother; 2007; 30(4):438-47. PubMed ID: 17457218
[TBL] [Abstract][Full Text] [Related]
14. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
[TBL] [Abstract][Full Text] [Related]
15. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
Vahlenkamp TW; Tompkins MB; Tompkins WA
J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
17. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.
Earle KE; Tang Q; Zhou X; Liu W; Zhu S; Bonyhadi ML; Bluestone JA
Clin Immunol; 2005 Apr; 115(1):3-9. PubMed ID: 15870014
[TBL] [Abstract][Full Text] [Related]
18. In vivo depletion of CD4+CD25+ regulatory T cells in cats.
Smithberg SR; Fogle JE; Mexas AM; Reckling SK; Lankford SM; Tompkins MB; Dean GA
J Immunol Methods; 2008 Jan; 329(1-2):81-91. PubMed ID: 17980384
[TBL] [Abstract][Full Text] [Related]
19. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
Masuyama J; Kaga S; Kano S; Minota S
J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
[TBL] [Abstract][Full Text] [Related]
20. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
